These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 756823)

  • 1. Pharmacokinetics and disposition of delta 9-tetrahydrocannabinol and its metabolites.
    Garrett ER
    Adv Biosci; 1978 Jul 22-23; 22-23():105-21. PubMed ID: 756823
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man.
    Wall ME; Perez-Reyes M
    J Clin Pharmacol; 1981; 21(S1):178S-189S. PubMed ID: 6271823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.
    Agurell S; Halldin M; Lindgren JE; Ohlsson A; Widman M; Gillespie H; Hollister L
    Pharmacol Rev; 1986 Mar; 38(1):21-43. PubMed ID: 3012605
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.
    Schaefer N; Kettner M; Laschke MW; Schlote J; Ewald AH; Menger MD; Maurer HH; Schmidt PH
    Curr Neuropharmacol; 2017; 15(5):713-723. PubMed ID: 27834143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man.
    Hunt CA; Jones RT; Herning RI; Bachman J
    J Pharmacokinet Biopharm; 1981 Jun; 9(3):245-60. PubMed ID: 6270295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and brain levels of delta 6-THC and seven monooxygenated metabolites correlated to the cataleptic effect in the mouse.
    Ohlsson A; Widman M; Carlsson S; Ryman T; Strid C
    Acta Pharmacol Toxicol (Copenh); 1980 Oct; 47(4):308-17. PubMed ID: 6258385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol and delta 9-tetrahydrocannabinol metabolism. In vitro comparison of mouse and rat liver crude microsome preparations.
    Borys HK; Karler R
    Biochem Pharmacol; 1979 May; 28(9):1553-9. PubMed ID: 475867
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of in vivo liver metabolites of delta 1-tetra-hydrocannabinol, cannabidiol, and cannabinol produced by the guninea-pig.
    Harvey DJ; Martin BR; Paton WD
    J Pharm Pharmacol; 1980 Apr; 32(4):267-71. PubMed ID: 6103056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain.
    Alozie SO; Martin BR; Harris LS; Dewey WL
    Pharmacol Biochem Behav; 1980 Feb; 12(2):217-21. PubMed ID: 6246544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of n-hexyl-homologues of delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in the mouse.
    Brown NK; Harvey DJ
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):165-76. PubMed ID: 2853671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity.
    Dinis-Oliveira RJ
    Drug Metab Rev; 2016; 48(1):80-7. PubMed ID: 26828228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in LC-MS/MS analysis of Δ(9)-tetrahydrocannabinol and its metabolites in biological matrices.
    Ferreirós N
    Bioanalysis; 2013 Nov; 5(21):2713-31. PubMed ID: 24180509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo metabolism of cannabinol by the mouse and rat and a comparison with a metabolism of delta 1-tetrahydrocannabinol and cannabidiol.
    Harvey DJ; Martin BR; Paton WD
    Biomed Mass Spectrom; 1977 Dec; 4(6):364-70. PubMed ID: 597586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
    Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
    Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of pH and temperature on the in vitro bindings of delta-9-tetrahydrocannabinol and other cannabinoids to bovine serum albumin.
    Papa VM; Shen ML; Ou DW
    J Pharm Biomed Anal; 1990; 8(4):353-6. PubMed ID: 1966044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The properties of UDP-glucuronyltransferase for cannabinoids in rat liver microsomes.
    Watanabe K; Kita M; Yamamoto I; Oguri K; Yoshimura H
    J Pharmacobiodyn; 1983 Aug; 6(8):581-7. PubMed ID: 6315914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetics of cannabinoid distribution and storage with special reference to the brain and testis.
    Nahas G; Leger C; Tocque B; Hoellinger H
    J Clin Pharmacol; 1981; 21(S1):208S-214S. PubMed ID: 6271826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of cannabinoids with bovine serum albumin.
    Haque SJ; Poddar MK
    Biosci Rep; 1984 Mar; 4(3):239-43. PubMed ID: 6326885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the disposition of 14C-delta 9-tetrahydrocannabinol and 3H-delta 9-tetrahydrocannabinol.
    Siemens AJ; Doyle OL; Pryor GT
    Life Sci; 1979 Apr; 24(14):1261-74. PubMed ID: 470542
    [No Abstract]   [Full Text] [Related]  

  • 20. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.
    Kemp PM; Abukhalaf IK; Manno JE; Manno BR; Alford DD; Abusada GA
    J Anal Toxicol; 1995 Sep; 19(5):285-91. PubMed ID: 7500614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.